Investing to become financially independent
Investing to become financially independent
Discover the detailed analysis of Novartis, the pharmaceutical giant born from the merger of Ciba-Geigy and Sandoz, and its dividend policy that raises ethical and economic questions. Between job cuts and sustainable dividend growth, let's explore how this global leader in pharma balances its social responsibilities and financial performance.
Novartis (VTX:NOVN) Read More »
During the market downturn in May, dividend-yielding stocks and the appreciation of the dollar helped maintain portfolio stability. Following this correction, which brings valuations back to more reasonable levels, a cautious and selective approach should be adopted for future investments.
Sell in May and go away Read More »
Meet Emerson Electric Company, an American multinational corporation that stands out as a quiet force in the field of industrial and commercial engineering. Despite modest dividend growth, the company demonstrates remarkable financial stability and an ability to generate regular income, regardless of economic fluctuations.
Emerson Electric (NYSE:EMR) Read More »
AstraZeneca, the pharmaceutical giant born from the merger of Astra AB and Zeneca PLC, has established itself as one of the world leaders in the sector with around 100,000 employees dedicated to the research, development and marketing of pharmaceutical products. The group presents solid financial indicators, with an attractive yield and a generous dividend distribution policy, although investors should be cautious due to the relative youth of its successive dividend increases.
Astrazeneca (NYSE:AZN) Read More »
Discover the in-depth analysis of Leggett & Platt, a leading U.S. furniture and bedding component company that is facing significant financial challenges. Despite an impressive dividend history, the company is struggling to cover its distributions and rising raw material costs, raising questions about its attractiveness to investors.
Leggett & Platt (NYSE:LEG) Read More »
Discover Praxair Inc (NYSE:PX), a leading North and South American supplier of industrial gases, distinguished by its global presence and impressive patent portfolio. Despite solid stock performance and stable dividend growth, its current valuation suggests a holding strategy for existing investors rather than a new buying opportunity.
Johnson & Johnson, an American healthcare giant founded in 1886, is one of the world's largest manufacturers of pharmaceutical, medical and cosmetic products with iconic brands such as Tylenol, Band-Aid and Neutrogena. The company stands out for its impressive history of growing dividends for decades, offering attractive stability for investors despite a slightly high payout ratio.
Johnson & Johnson (NYSE:JNJ) Read More »
Discover Sigma-Aldrich, the American giant in the production of chemicals and equipment for scientific research, present worldwide with over a million customers. Despite its defensive nature and reasonable volatility, the share currently offers a high valuation that merits careful monitoring before any investment.
Sigma-Aldrich (Nasdaq:SIAL) Read More »